- Rapidly aging population, especially in some developed countries leading to increasing number of men with testosterone deficiency spells growth
- Focus of keen players to seek regulatory approvals for new therapies, generic version of established therapies to expand growth vistas
ALBANY, N.Y., April 22, 2021 /PRNewswire/ -- Testosterone replacement therapy is widely used treatment for men with symptomatic hypogonadism. The benefits of testosterone replacement therapy manifest as increased energy and libido level, improved bone density and strength, improved muscle strength, and cardioprotective effects. According to The Baltimore Longitudinal Study of Aging, 20% hypogonadism is reported in men over the age of 60 years, 30% in men over 70 years, and 50% in men over 80 years.
Testosterone replacement therapy is a reasonable treatment option often used for men with low testosterone levels and symptoms of hypogonadism. When testosterone is replaced, a number of positive effects of higher testosterone levels are experienced. Thus, the positive results of such therapy has led to a substantial demand for testosterone replacement therapy for men with symptomatic hypogonadism, though there is insufficient data for long-term efficacy and safety of the therapy.
Request for Analysis of COVID-19 Impact on Testosterone Replacement Therapy Market - https://www.transparencymarketresearch.com/covid19.php
Nonetheless, the beneficial effects of testosterone replacement therapy is rarely disputed instead widely publicized that marks bright prospects for the testosterone replacement therapy market. As such, in the near-term, from 2019 to 2027, the testosterone replacement therapy market is predicted to rise at a solid 4.4% CAGR.
Testosterone Replacement Therapy - Key Findings of the Report
Keen Players seeking Regulatory Approvals for Launch of New Therapies points at Bright Future
Key players in the testosterone replacement therapy market are undertaking efforts to obtain regulatory approvals for launch of new products, integration of novel technologies, and M&As and collaborations with other companies. For example, in the recent past, the U.S. FDA provided approval for a generic testosterone gel to use for testosterone replacement therapy for men with symptomatic hypogonadism. In another example, in March 2019, an oral testosterone capsule produced by Clarus Therapeutics received approval of the U.S. FDA for the treatment of certain forms of hypogonadism.
Request Brochure of Testosterone Replacement Therapy Market Report - https://www.transparencymarketresearch.com/brochure.php
While North America to remain Prominent, Asia Pacific to display Stellar Growth Rate
Factors such as increasing adoption of testosterone replacement therapy and high awareness of availability of convenient treatment options makes North America prominent region in the testosterone replacement therapy market.
On the other hand, Asia Pacific is anticipated to chart an impressive growth rate in the testosterone replacement therapy market in the forthcoming years. Focus of key players to target emerging economies in the region such as India, wherein rising disposable incomes is leading to demand for treatment of unconventional health conditions is creating opportunities in the testosterone replacement therapy market of the region. Besides this, a large population base with testosterone deficiency due to several factors in various countries offers immense prospects for testosterone replacement therapy market of the region.
Purchase the Testosterone Replacement Therapy Market Report - https://www.transparencymarketresearch.com/checkout.php
Solid Marketing Programs to create Awareness Paints Strokes of Growth
Leading players in the testosterone replacement therapy market are undertaking solid marketing programs to promote their branded products, and at the same time create awareness among the general population. Companies in the testosterone replacement therapy market are promoting their products directly to consumers and physicians via journals, meetings, and events.
Testosterone Replacement Therapy - Growth Drivers
- Continually rising acceptance for testosterone replacement therapy, in the umbrella of hormone replacement therapies due to large number of cases that validate efficacy and benefits of the same paints strokes of growth.
- Exploding geriatric population in several parts of the world with high risk of testosterone deficiency fuels growth.
Request for Custom Research - https://www.transparencymarketresearch.com/custom-research.php
Testosterone Replacement Therapy - Key Players
- AbbVie Inc.
- Bayer AG
- Eli Lilly and Company
- Mylan N.V.
- Pfizer Inc.
- Ferring Holding SA
- Allergan plc
- Endo Pharmaceuticals Inc.
- Kyowa Kirin International plc
- Novartis AG
- Clarus Therapeutics
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Continuous Renal Replacement Therapy Market: https://www.transparencymarketresearch.com/continuous-renal-replacement-therapy-market.html
Primary Immunodeficiency Market: https://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."
Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/testosterone-replacement-therapy.htm
Website: https://www.transparencymarketresearch.com/
LOGO: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg
